BioSpace News Archive

Astria Therapeutics, Inc. today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming virtual Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13th at 9:20am ET.

Medidata and Sanofi Vaccines, today announced a collaboration to harness Medidata eCOA to deploy in vaccine studies.

RapidA will showcase its clinical expertise and industry-leading innovation at the American Heart Association’s International Stroke Conference (ISC) in Phoenix, AZ, February 7-9.

Inozyme Pharma, Inc. today announced that it granted stock options to four new employees to purchase shares of the Company’s common stock.

BioSig Technologies, Inc. announced that physicians have completed over 100 cases with the Near Field Tracking algorithm, an innovative and proprietary feature recently launched on the Company’s PURE EP™ Platform.

Processa Pharmaceuticals, Inc. announces it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on the Nasdaq Market and that the matter is now closed.

Evaxion Biotech A/S today announced the closing on February 5, 2024 of its previously announced public offering of 3,750,000 of its American Depositary Shares.

SELLAS Life Sciences Group, Inc. today announced a publication in Oncotarget revealing the underlying mechanisms of action behind the anti-proliferative effects of SLS009 (formerly GFH009).

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, is pleased to announce the initiation of Good Manufacturing Practice (GMP) manufacturing of its lead candidate for treating prostate cancer, Bria-Pros+.

Celerion , a leading clinical research organization, proudly announces its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art bioanalytical laboratory located in Lincoln, Nebraska.